Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
3
×
boston blog main
life sciences
national blog main
national top stories
new york blog main
3
×
biogen
boston top stories
boulder/denver blog main
boulder/denver top stories
cancer
clinical trials
crispr
detroit blog main
detroit top stories
fda
gene therapy
indiana blog main
indiana top stories
ipo
national
new york top stories
novartis
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
seattle blog main
seattle top stories
startups
texas blog main
texas top stories
venture capital
wisconsin blog main
wisconsin top stories
2025
abbvie
ad-comm
What
years
3
×
bio
ipo
medicines
roundup
therapeutics
acquisitions
adding
ago
aiming
allogene
announced
balance
build
cancer
ceo
collabs
covid
crispr
daniel
deal
decibel
diversity
drugs
emerged
focus
forms
gilead
gilead’s
hearing
help
hot
immunotherapy
introduce
investors
juno
loss
med
million
month
Language
unset
Current search:
years
×
biotech
×
" new york blog main "
×
@xconomy.com
4 years ago
Bio Roundup: Gilead’s $4.9B Deal, COVID-19 Collabs, IPO Plans & More
@xconomy.com
4 years ago
Decibel Therapeutics Strikes a Balance, Adding Regenerative Med Focus
@xconomy.com
5 years ago
Bio Roundup: BIO Diversity, Allogene IPO, CRISPR In Utero & More